Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tyra Biosciences, Inc.

10.92
+0.79007.80%
Post-market: 10.920.00000.00%16:21 EDT
Volume:222.55K
Turnover:2.38M
Market Cap:580.70M
PE:-6.68
High:10.95
Open:10.26
Low:10.20
Close:10.13
Loading ...
Jun 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Correspondence

Form CORRESP - Correspondence
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities